Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds
Miriam Redondo(Instituto de Química Médica), Carmen Gil(Instituto de Salud Carlos III), Marı́a Isabel Cadavid(Universidade de Santiago de Compostela), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), José Á. Morales-García(Universitat de Vic - Universitat Central de Catalunya), Ana Pérez‐Castillo(Instituto de Investigaciones Biomédicas Sols-Morreale), José Brea(Universidade de Santiago de Compostela), Daniel I. Pérez(Cedars-Sinai Medical Center), Guadalupe Mengod(Consejo Superior de Investigaciones Científicas), Nuria Paúl-Fernández(Biomedical Research Networking Center on Neurodegenerative Diseases), Cristina Val(Universidade de Santiago de Compostela), Ignacio Soteras(Instituto de Química Médica), Sandra Alonso‐Gil(Biomedical Research Networking Center on Neurodegenerative Diseases), Concepción Pérez(Instituto de Química Médica), Marı́a Isabel Martı́n(Biomedical Research Networking Center on Neurodegenerative Diseases), Marı́a Isabel Loza(Universidade de Santiago de Compostela), Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas)
Cited by 57
Related Papers
Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding
|Journal of Neuroscience|1992|689
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
|PLoS Pathogens|2016|451
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348